Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
FT596
i
Other names:
CAR19/hnCD16/IL15/R iNK Cell, FT596, iPSC-derived CAR NK Cell Cancer Immunotherapy, CAR NK Cell Cancer Immunotherapy
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Fate Therap
Drug class:
CD19 inhibitor, IL-15R stimulant, CD16A inhibitor
Related drugs:
‹
blinatumomab (52)
tafasitamab-cxix (3)
A-319 (2)
CLN-978 (1)
YT-19 (1)
AFM11 (0)
ALA-101 (0)
AMG 562 (0)
AZD0486 (0)
BTN2A1/3A1-Fc-CD19scFv (0)
CAR-NK-CD19 cells (0)
CAR19-CYNK (0)
CB CAR-NK019 (0)
CD19.t-haNK (0)
CMG1A46 (0)
CNTY-101 (0)
Imtox19/Imtox22 (0)
ET-190 (0)
FT522 (0)
GNR-084 (0)
JD001 (0)
JD010 (0)
KN5501 (0)
NKX019 (0)
ONKT101 (0)
PIT565 (0)
QN-019a (0)
RG6333 (0)
RGV004 (0)
SNC103 (0)
TAC01-CD19 (0)
TAK-007 (0)
TC-110 (0)
TG-1801 (0)
inebilizumab-cdon (0)
YT-19/22 (0)
anti CD19/CD22 CAR NK cells (0)
autologous TRAC locus-inserted CD19-STAR-T (0)
dualCAR-NK19/70 (0)
GNC-038 (0)
RG6076 (0)
CF33-CD19 (0)
universal chimeric antigen receptor-modified AT19 cells (0)
SAR445710 (2)
ACTM-838 (0)
AGAR T cells (0)
FT538 (0)
GT-00A x IL15 (0)
GTB-3550 TRIKE (0)
GTB-3650 (0)
HCW9218 (0)
NIZ985 (0)
PF-07209960 (0)
RPTR-147:1 (0)
RTX-240 (0)
SAR445877 (0)
VG161 (0)
VG201 (0)
iC9.GD2.CAR.IL-15 T-cells (0)
blinatumomab (52)
tafasitamab-cxix (3)
A-319 (2)
CLN-978 (1)
YT-19 (1)
AFM11 (0)
ALA-101 (0)
AMG 562 (0)
AZD0486 (0)
BTN2A1/3A1-Fc-CD19scFv (0)
CAR-NK-CD19 cells (0)
CAR19-CYNK (0)
CB CAR-NK019 (0)
CD19.t-haNK (0)
CMG1A46 (0)
CNTY-101 (0)
Imtox19/Imtox22 (0)
ET-190 (0)
FT522 (0)
GNR-084 (0)
JD001 (0)
JD010 (0)
KN5501 (0)
NKX019 (0)
ONKT101 (0)
PIT565 (0)
QN-019a (0)
RG6333 (0)
RGV004 (0)
SNC103 (0)
TAC01-CD19 (0)
TAK-007 (0)
TC-110 (0)
TG-1801 (0)
inebilizumab-cdon (0)
YT-19/22 (0)
anti CD19/CD22 CAR NK cells (0)
autologous TRAC locus-inserted CD19-STAR-T (0)
dualCAR-NK19/70 (0)
GNC-038 (0)
RG6076 (0)
CF33-CD19 (0)
universal chimeric antigen receptor-modified AT19 cells (0)
SAR445710 (2)
ACTM-838 (0)
AGAR T cells (0)
FT538 (0)
GT-00A x IL15 (0)
GTB-3550 TRIKE (0)
GTB-3650 (0)
HCW9218 (0)
NIZ985 (0)
PF-07209960 (0)
RPTR-147:1 (0)
RTX-240 (0)
SAR445877 (0)
VG161 (0)
VG201 (0)
iC9.GD2.CAR.IL-15 T-cells (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
CD19 positive + CD20 positive
Burkitt Lymphoma
CD19 positive + CD20 positive
Burkitt Lymphoma
rituximab + FT596
Sensitive: D – Preclinical
rituximab + FT596
Sensitive
:
D
rituximab + FT596
Sensitive: D – Preclinical
rituximab + FT596
Sensitive
:
D
CD19 positive
Acute Lymphocytic Leukemia
CD19 positive
Acute Lymphocytic Leukemia
FT596
Sensitive: D – Preclinical
FT596
Sensitive
:
D
FT596
Sensitive: D – Preclinical
FT596
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login